Avapritinib
Back to searchMolecule Structure
Scientific Name
Avapritinib
Description of the Drug
Avapritinib is a selective tyrosine kinase inhibitor being investigated for the treatment of multidrug resistant gastrointestinal tumors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15233
http://www.drugbank.ca/drugs/DB15233
Brand Name(s)
Ayvakit
Company Owner(s)
Blueprint Medicines Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Platelet-derived growth factor receptor alpha | SINGLE PROTEIN | INHIBITOR | CHEMBL2007 |
| Stem cell growth factor receptor | SINGLE PROTEIN | INHIBITOR | CHEMBL1936 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16652297 | |
| Human Metabolome Database | HMDB0304850 | |
| DrugBank | DB15233 | |
| PubChem | 118023034 | |
| BindingDB | 469269 | |
| DrugCentral | 5379 | |
| ChemicalBook | CB13171751 | |
| Guide to Pharmacology | 10368 | |
| rxnorm | AYVAKIT | AVAPRITINIB |
